96 related articles for article (PubMed ID: 10189170)
1. Acceleration of lupus erythematosus-like processes by low frequency noise in the hybrid NZB/W mouse model.
Aguas AP; Esaguy N; Grande NR; Castro AP; Castelo Branco NA
Aviat Space Environ Med; 1999 Mar; 70(3 Pt 2):A132-6. PubMed ID: 10189170
[TBL] [Abstract][Full Text] [Related]
2. Effect low frequency noise exposure on BALB/c mice splenic lymphocytes.
Aguas AP; Esaguy N; Grande N; Castro AP; Castelo Branco NA
Aviat Space Environ Med; 1999 Mar; 70(3 Pt 2):A128-31. PubMed ID: 10189169
[TBL] [Abstract][Full Text] [Related]
3. Male New Zealand Black/KN mice: a novel model for autoimmune-induced permanent alopecia?
Hiroi A; Ito T; Seo N; Uede K; Yoshimasu T; Ito M; Nakamura K; Ito N; Paus R; Furukawa F
Br J Dermatol; 2006 Aug; 155(2):437-45. PubMed ID: 16882186
[TBL] [Abstract][Full Text] [Related]
4. Increase in CD8+ and CD4+ T lymphocytes in patients with vibroacoustic disease.
Castro AP; Aguas AP; Grande NR; Monteiro E; Castelo Branco NA
Aviat Space Environ Med; 1999 Mar; 70(3 Pt 2):A141-4. PubMed ID: 10189172
[TBL] [Abstract][Full Text] [Related]
5. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
6. An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus.
Bahjat FR; Pine PR; Reitsma A; Cassafer G; Baluom M; Grillo S; Chang B; Zhao FF; Payan DG; Grossbard EB; Daikh DI
Arthritis Rheum; 2008 May; 58(5):1433-44. PubMed ID: 18438845
[TBL] [Abstract][Full Text] [Related]
7. Role of distinct immune components in the radiation-induced abrogation of systemic lupus erythematosus development in mice.
e Brito RR; De Lorenzo BH; Xander P; Godoy LC; Lopes JD; da Silva NP; Sampaio SC; Mariano M
Lupus; 2007; 16(12):947-54. PubMed ID: 18042588
[TBL] [Abstract][Full Text] [Related]
8. Genetic control of the spontaneous activation of CD4+ Th cells in systemic lupus erythematosus-prone (NZB x NZW) F1 mice.
Fujii T; Iida Y; Yomogida M; Ikeda K; Haga T; Jikumaru Y; Ninami M; Nishimura N; Kodera Y; Inada Y; Shirai T; Hirose S; Nishimura H
Genes Immun; 2006 Dec; 7(8):647-54. PubMed ID: 17024131
[TBL] [Abstract][Full Text] [Related]
9. Regulation of immune function by calorie restriction and cyclophosphamide treatment in lupus-prone NZB/NZW F1 mice.
Sun D; Krishnan A; Su J; Lawrence R; Zaman K; Fernandes G
Cell Immunol; 2004 Mar; 228(1):54-65. PubMed ID: 15203320
[TBL] [Abstract][Full Text] [Related]
10. Sophorae radix reduces autoimmune response in NZB/w F1 systemic lupus erythematosus mouse model.
Ko E; Lee Y; Park N; Cho C; Yim YN; Kim J; Kim YS; Kim D; Shin MK; Hong MC; Bae H
Lupus; 2007; 16(5):335-41. PubMed ID: 17576735
[TBL] [Abstract][Full Text] [Related]
11. B cell apoptosis accelerates the onset of murine lupus.
Trébéden-Nègre H; Weill B; Fournier C; Batteux F
Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
[TBL] [Abstract][Full Text] [Related]
12. Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model.
Borel P; Benkhoucha M; Weber MS; Zamvil SS; Santiago-Raber ML; Lalive PH
Int Immunol; 2008 Oct; 20(10):1313-9. PubMed ID: 18687587
[TBL] [Abstract][Full Text] [Related]
13. Ongoing immunologic activity after short courses of pulse cyclophosphamide in the NZB/W murine model of systemic lupus erythematosus.
Austin HA; Patel AD; Cadena CA; Boumpas DT; Balow JE
J Rheumatol; 1997 Jan; 24(1):61-8. PubMed ID: 9002012
[TBL] [Abstract][Full Text] [Related]
14. The effect of chronic exposure to low frequency noise on rat tracheal epithelia.
De Sousa Pereira A; Aguas AP; Grande NR; Mirones J; Monteiro E; Castelo Branco NA
Aviat Space Environ Med; 1999 Mar; 70(3 Pt 2):A86-90. PubMed ID: 10189161
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
16. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
[TBL] [Abstract][Full Text] [Related]
17. Accelerated deaths from systemic lupus erythematosus in NZB x NZW F1 mice treated with the testosterone-blocking drug flutamide.
Walker SE; Besch-Williford CL; Keisler DH
J Lab Clin Med; 1994 Sep; 124(3):401-7. PubMed ID: 8083583
[TBL] [Abstract][Full Text] [Related]
18. The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice.
Reilly CM; Thomas M; Gogal R; Olgun S; Santo A; Sodhi R; Samy ET; Peng SL; Gilkeson GS; Mishra N
J Autoimmun; 2008 Sep; 31(2):123-30. PubMed ID: 18650065
[TBL] [Abstract][Full Text] [Related]
19. Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus.
Wang X; Huang W; Schiffer LE; Mihara M; Akkerman A; Hiromatsu K; Davidson A
Arthritis Rheum; 2003 Feb; 48(2):495-506. PubMed ID: 12571860
[TBL] [Abstract][Full Text] [Related]
20. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
